Advertisement

HIV-Infektion und assoziierte opportunistische Infektionen

  • W. Enzensberger
  • E. Schielke
Chapter

Zusammenfassung

Mehr als die Hälfte aller HIV-infizierten Patienten entwickelt im Verlauf der Erkrankung neurologische Symptome. Bei ungefähr 10% handelt es sich dabei um die klinische Erstmanifestation der Krankheit. Viele neurologische Komplikationen sind gut behandelbar (Tabelle 26-1), z.T. sogar ambulant. In anderen Fällen ist eine intensivmedizinische Therapie erforderlich, seltener wegen des neurologischen Leidens, häufiger wegen zusätzlicher internistischer, insbesondere pulmonaler Komplikation (ca. 10% aller HIV-Patienten).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anonymous (1996) Update: Provisional Public Health Service recommendations for chemo-prophylaxis after occupational exposure to HIV. MMWR 45:468–472.Google Scholar
  2. Baceliar H, Munoz A, Miller EN et al. (1994) Temporal trends in the incidence of HIV 1-related neurologic diseases: Multicenter Aids cohort study, 1985-1992. Neurology 44:1892–1900.CrossRefGoogle Scholar
  3. Bartlett JG (1992) Recommendations for the medical care of persons with HIV infection. Crit Care Am 1:44–49.Google Scholar
  4. Baumgartner JE, Rachlin JR, Beckstead JH et al. (1990) Primary central nervous system lymphomas: Natural history and response to radiation therapy in 55 patients with the acquired immunodeficiency syndrome. J Neurosurg 73:206–211.CrossRefPubMedGoogle Scholar
  5. Berenguer J, Moreno S, Laguna F et al. (1992) Tuberculous meningitis in patients with the human immunodeficiency virus. N Engl J Med 326:668–672.CrossRefPubMedGoogle Scholar
  6. Brodt HR, Hoka R, Helm EB (1993) Die HIV-Infektion unter dem Aspekt einer intensivmedizinischen bzw. chirurgischen Behandlung. In: L’Age-Stehr, Helm EB (Hrsg) Aids und die Vorstadien. Springer, Berlin Heidelberg New York Tokyo, S IV.2. 1–8.Google Scholar
  7. Chuck SL, Sande ME (1989) Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 321:794–799.CrossRefPubMedGoogle Scholar
  8. Cohen BA (1996) Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in Aids. Neurology 46:444–450.CrossRefPubMedGoogle Scholar
  9. Cornblath DR, Chaudrhy V, Griftin JW (1991) Treatment of chronic inflammatory demyeli-nating polyneuropathy with intravenous immunoglobulin. Ann Neurol 30:104–106.CrossRefPubMedGoogle Scholar
  10. De Luca A, Antinori A, Congolani A et al. (1995) Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of Aids-related primary central nervous system lymphoma. Br J Haematol 90:844–849.CrossRefPubMedGoogle Scholar
  11. Engström JW, Lowenstein DH, Bredesen DE (1989) Cerebral infarctions and transient neurological deficits associated with acquired immunodeficiency syndrome. Am J Med 86:528–532.CrossRefPubMedGoogle Scholar
  12. Enzensberger W, Royal III W (1994) HIV infection and associated opportunistic infections. In: Hacke W, Hanley DF, Einhäupl KM et al. (eds) Neurocritical Care. Springer, Berlin Heidelberg New York Tokyo, pp 500–511.CrossRefGoogle Scholar
  13. Fischer PA, Enzensberger W (1987) Neurological complications in Aids. J Neuro 234:269–279.CrossRefGoogle Scholar
  14. Fox JD, Brink NS, Zuckermann MA et al. (1995) Detection of herpesvirus DNA by nested polymerase chain reaction in cerebrospinal fluid of human immunodeficiency virus-infected persons with neurologic disease: a prospective evaluation. J Infect Dis 172:1087–1090.CrossRefPubMedGoogle Scholar
  15. Gerberding JL (1996) Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study. J Infect Dis 170:1410–1417.CrossRefGoogle Scholar
  16. Gerberding JL (1996) Prophylaxis for occupational exposure to HIV. Ann Intern Med 125:497–501.CrossRefPubMedGoogle Scholar
  17. Kim YS, Hollander H (1993): Polyradiculopathy due to cytomegalovirus: Report of two cases in which improvement occured after prolonged therapy and review of the literature. Clin Infect Dis 17:32–37.CrossRefPubMedGoogle Scholar
  18. Luft BJ, Remington JS (1987) Toxoplasmic encephalitis. J Infect Dis 157:1–6.CrossRefGoogle Scholar
  19. Wächter RM, Luce JM, Hopewell PC (1992) Critical care of patients with Aids. JAMA 267:541–547.CrossRefPubMedGoogle Scholar
  20. Weber T, Turner RT, Frye S et al. (1994) Specific diagnosis of progressive multifocal leu-koencephalopathy by polymerase chain reaction. J Infect Dis 169:1138–1141.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • W. Enzensberger
  • E. Schielke

There are no affiliations available

Personalised recommendations